Noticias
Ya se han lanzado las 11ª y 12ª convocatorias IMI : - IMI 2 (Call 11) que consiste en un único topic: Exploitation of IMI project results - IMI 2 (Call 12) con los siguientes topics: Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD) FAIRification of IMI and EFPIA data Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS) European health data network (EHDN) Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolicdiseases European Screening Centre: unique library for attractive biology (ESCulab) La herramienta IMI de búsqueda de socios es: www.
19/07 Junior Leader Fellowships Programme- "La Caixa Foundation"
Ya se han lanzado las 11ª y 12ª convocatorias IMI : - IMI 2 (Call 11) que consiste en un único topic: Exploitation of IMI project results - IMI 2 (Call 12) con los siguientes topics: Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD) FAIRification of IMI and EFPIA data Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS) European health data network (EHDN) Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolicdiseases European Screening Centre: unique library for attractive biology (ESCulab) La herramienta IMI de búsqueda de socios es: www.
23/04 ENCUENTROS CON EXPERTOS EN MEDICINA CARDIOVASCULAR
Ya se han lanzado las 11ª y 12ª convocatorias IMI : - IMI 2 (Call 11) que consiste en un único topic: Exploitation of IMI project results - IMI 2 (Call 12) con los siguientes topics: Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD) FAIRification of IMI and EFPIA data Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS) European health data network (EHDN) Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolicdiseases European Screening Centre: unique library for attractive biology (ESCulab) La herramienta IMI de búsqueda de socios es: www.
PREMIOS VI Jornada de Investigación e Innovación del IiSGM
Ya se han lanzado las 11ª y 12ª convocatorias IMI : - IMI 2 (Call 11) que consiste en un único topic: Exploitation of IMI project results - IMI 2 (Call 12) con los siguientes topics: Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD) FAIRification of IMI and EFPIA data Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS) European health data network (EHDN) Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolicdiseases European Screening Centre: unique library for attractive biology (ESCulab) La herramienta IMI de búsqueda de socios es: www.
SEMINARIO CIB Dr. Jacco Van Rheenen 16/03/2018
Ya se han lanzado las 11ª y 12ª convocatorias IMI : - IMI 2 (Call 11) que consiste en un único topic: Exploitation of IMI project results - IMI 2 (Call 12) con los siguientes topics: Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD) FAIRification of IMI and EFPIA data Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS) European health data network (EHDN) Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolicdiseases European Screening Centre: unique library for attractive biology (ESCulab) La herramienta IMI de búsqueda de socios es: www.
10/12 INPhINIT Programme- "La Caixa Foundation"
Ya se han lanzado las 11ª y 12ª convocatorias IMI : - IMI 2 (Call 11) que consiste en un único topic: Exploitation of IMI project results - IMI 2 (Call 12) con los siguientes topics: Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD) FAIRification of IMI and EFPIA data Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS) European health data network (EHDN) Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolicdiseases European Screening Centre: unique library for attractive biology (ESCulab) La herramienta IMI de búsqueda de socios es: www.
05/06 CERTIFICACIÓN IiSGM SEGÚN LA NORMA UNE EN ISO 9001:2015
Ya se han lanzado las 11ª y 12ª convocatorias IMI : - IMI 2 (Call 11) que consiste en un único topic: Exploitation of IMI project results - IMI 2 (Call 12) con los siguientes topics: Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD) FAIRification of IMI and EFPIA data Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS) European health data network (EHDN) Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolicdiseases European Screening Centre: unique library for attractive biology (ESCulab) La herramienta IMI de búsqueda de socios es: www.
16/10 IMPLEMENTACIÓN FUNDANET CIENTÍFICO IiSGM
Ya se han lanzado las 11ª y 12ª convocatorias IMI : - IMI 2 (Call 11) que consiste en un único topic: Exploitation of IMI project results - IMI 2 (Call 12) con los siguientes topics: Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD) FAIRification of IMI and EFPIA data Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS) European health data network (EHDN) Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolicdiseases European Screening Centre: unique library for attractive biology (ESCulab) La herramienta IMI de búsqueda de socios es: www.
21/08 I JORNADAS DE ACTUALIZACIÓN EN IMPRESIÓN 3D MÉDICA IiSGM
Ya se han lanzado las 11ª y 12ª convocatorias IMI : - IMI 2 (Call 11) que consiste en un único topic: Exploitation of IMI project results - IMI 2 (Call 12) con los siguientes topics: Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD) FAIRification of IMI and EFPIA data Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS) European health data network (EHDN) Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolicdiseases European Screening Centre: unique library for attractive biology (ESCulab) La herramienta IMI de búsqueda de socios es: www.
19/07 11ª Y 12ª CONVOCATORIA IMI
Ya se han lanzado las 11ª y 12ª convocatorias IMI : - IMI 2 (Call 11) que consiste en un único topic: Exploitation of IMI project results - IMI 2 (Call 12) con los siguientes topics: Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD) FAIRification of IMI and EFPIA data Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS) European health data network (EHDN) Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolicdiseases European Screening Centre: unique library for attractive biology (ESCulab) La herramienta IMI de búsqueda de socios es: www.